Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,128 public trials 394 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study

NCT00275444

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
  • Living Hope Clinical Trials, Inc. Long Beach, California, United States
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

NCT00056641

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Boehringer Ingelheim Investigational Site Berkeley, California, United States
  • Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 109 locations
View Trial Details
Completed

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

NCT05152953

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Auburn University Harrison School of Pharmacy Auburn, Alabama, United States
  • University of California San Francisco School of Pharmacy San Francisco, California, United States
  • Nova Southeastern University College of Pharmacy Fort Lauderdale, Florida, United States
  • Texas A&M Irma Lerma Rangel College of Pharmacy Kingsville, Texas, United States
View Trial Details
Completed

Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas

NCT01193842

Conditions
AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, +39 more
Locations
  • Jackson Hospital and Clinic Montgomery, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
View all 35 locations
View Trial Details

Related conditions